MC1221A1 - IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS AND THE INTERMEDIATE PRODUCTS, AND THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SUBSTANCES - Google Patents

IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS AND THE INTERMEDIATE PRODUCTS, AND THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SUBSTANCES

Info

Publication number
MC1221A1
MC1221A1 MC781335A MC1335A MC1221A1 MC 1221 A1 MC1221 A1 MC 1221A1 MC 781335 A MC781335 A MC 781335A MC 1335 A MC1335 A MC 1335A MC 1221 A1 MC1221 A1 MC 1221A1
Authority
MC
Monaco
Prior art keywords
synthesis
salts
substances
preparation
pharmaceutical compositions
Prior art date
Application number
MC781335A
Other languages
French (fr)
Inventor
P Thorogood
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1221A1 publication Critical patent/MC1221A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC781335A 1977-10-19 1978-10-18 IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS AND THE INTERMEDIATE PRODUCTS, AND THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SUBSTANCES MC1221A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB4353277 1977-10-19
GB4351277 1977-10-19
GB398478 1978-02-01

Publications (1)

Publication Number Publication Date
MC1221A1 true MC1221A1 (en) 1979-07-20

Family

ID=27254350

Family Applications (1)

Application Number Title Priority Date Filing Date
MC781335A MC1221A1 (en) 1977-10-19 1978-10-18 IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS AND THE INTERMEDIATE PRODUCTS, AND THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SUBSTANCES

Country Status (12)

Country Link
JP (1) JPS5488268A (en)
AT (1) AT370095B (en)
AU (1) AU522055B2 (en)
CA (1) CA1111433A (en)
DE (1) DE2845406A1 (en)
DK (1) DK464278A (en)
FI (1) FI783175A (en)
IE (1) IE47749B1 (en)
IL (1) IL55858A (en)
IT (1) IT1109321B (en)
MC (1) MC1221A1 (en)
ZA (1) ZA785863B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS6047257B2 (en) * 1979-07-19 1985-10-21 旭化成株式会社 Novel basic substances and their production methods
US4430445A (en) 1979-07-19 1984-02-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
GR78234B (en) * 1981-03-10 1984-09-26 Ciba Geigy Ag
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
ZA835967B (en) * 1982-08-14 1985-04-24 Wellcome Found Imidazole derivatives and salts thereof,their synthesis,and pharmaceutical formulations
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
JPH01316365A (en) * 1988-03-24 1989-12-21 Shikoku Chem Corp 1-benzylimidazole compound, synthesis thereof and curing of polyepoxy resin using said compound

Also Published As

Publication number Publication date
IE47749B1 (en) 1984-06-13
JPS5488268A (en) 1979-07-13
IL55858A (en) 1982-09-30
IT7851570A0 (en) 1978-10-18
ATA747378A (en) 1982-07-15
JPS6233227B2 (en) 1987-07-20
AU522055B2 (en) 1982-05-13
AT370095B (en) 1983-02-25
AU4082478A (en) 1980-04-24
DE2845406A1 (en) 1979-05-03
FI783175A (en) 1979-04-20
DK464278A (en) 1979-04-20
IT1109321B (en) 1985-12-16
CA1111433A (en) 1981-10-27
ZA785863B (en) 1980-05-28
IL55858A0 (en) 1979-01-31
IE782067L (en) 1979-04-19

Similar Documents

Publication Publication Date Title
LU80863A1 (en) IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USEFUL FOR THIS PURPOSE AND PHARMACEUTICAL COMPOSITIONS
FR2466248B1 (en) DERIVATIVES OF NON-STEROID ANTI-INFLAMMATORY AGENTS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA18829A1 (en) PYRIMIDINE DERIVATIVES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR THERAPEUTIC USE
FR2569404B1 (en) NOVEL 1,2-BENZISOTHIAZOL-3-YLPIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PROCESSES FOR THEIR PREPARATION
MC1119A1 (en) ISOQUINOLEINE DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES
PT85279A (en) PROCESS FOR THE PREPARATION OF NITROFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE874416A (en) NEW BENZENE PROPANAMINE DERIVATIVES AND THEIR SALTS, THEIR METHOD OF PREPARATION, THEIR APPLICATION AS MEDICINAL PRODUCTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2445319A1 (en) PYRIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE868796A (en) NEW DERIVATIVES OF 1-ACYL 2-CYANO-AZIRIDINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
BE881631A (en) NOVEL OXOIMIDAZOQUINOXALINE DERIVATIVES AND SALTS THEREOF, PROCESS FOR THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2505185B1 (en) PROCESS FOR THE PREPARATION OF AN INJECTABLE CHONDROITINE POLYSULFATE, PRODUCT OBTAINED BY THIS PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BE885385A (en) D-6-N-PROPYLERGOLINS DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2451910B1 (en) NOVEL AMINO-ALCOHOL DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE PRODUCTS
FR2305181A1 (en) NITROFURYLPYRAZOLE DERIVATIVES, METHODS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
MC1221A1 (en) IMIDAZOLE DERIVATIVES AND THEIR SALTS, THEIR SYNTHESIS AND THE INTERMEDIATE PRODUCTS, AND THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SUBSTANCES
MC1315A1 (en) IMIDAZOLE DERIVATIVES AND THEIR SYNTHESIS AND PREPARATION OF MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
IT1118277B (en) DERIVATIVES OF AZA I BICYCLE 2 2 2 OCTANO INTERMEDIATE PROCEDURES FOR THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS
BE856319A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ORGANIC DERIVATIVES OF MONTMORILLONITE
DE2861646D1 (en) Derivatives of furyl compounds, their preparation and pharmaceutical compositions containing them
PT74651B (en) PROCESS FOR THE PREPARATION OF PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BE815499A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAZOLO-ISOQUINOLEINE DERIVATIVES
PT82364B (en) PROCESS FOR THE PREPARATION OF NITROFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2319332A1 (en) NEW DERIVATIVES OF AMINOBENZOCYCLOHEPTENE AND THEIR SALTS, METHOD OF PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS OF THE SAID PRODUCTS
BE826711A (en) INDOLYLACETYLAMINO-ACID DERIVATIVES, THEIR PROCESS FOR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
BE875091A (en) SPIROOXAZOLIDINONE STEROIDIAN SUBSTITUTION DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
YP Annual fee paid